In human umbilical vein endothelial cells (HUVECs) treated with high glucose, overexpression of miR-320 can reduce expression of ET-1, vascular endothelial growth factor (VEGF), and fibronectin through inhibiting ERK1/2 to alleviate cardiac injury induced by diabetes [102]. The gene discussed is VEGFA; the disease is diabetes mellitus.